1LWF image
Deposition Date 2002-05-31
Release Date 2002-10-30
Last Version Date 2024-11-13
Entry Detail
PDB ID:
1LWF
Keywords:
TRANSFERASE
Title:
CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE
Biological Source:
Source Organism:
Human immunodeficiency virus 1 (Taxon ID: 11676)
Host Organism:
Escherichia coli
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.80 Å
R-Value Free:
0.28
R-Value Work:
0.23
Space Group:
P 21 21 21
1LWF validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:HIV-1 REVERSE TRANSCRIPTASE
Gene (Uniprot):gag-pol
Mutations:M41L/D67N/K70R/M184V/T215Y
Chain IDs:A
Chain Length:560
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
UniProt ID:P04585 Pfam ID:PF00078, PF06817, PF06815, PF00075
Protein Blast
Polymer Type:polypeptide(L)
Molecule:HIV-1 REVERSE TRANSCRIPTASE
Gene (Uniprot):gag-pol
Mutations:M41L/D67N/K70R/M184V/T215Y
Chain IDs:B
Chain Length:440
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
UniProt ID:P04585 Pfam ID:PF00078, PF06817, PF06815, PF00075
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CSD A CYS 3-SULFINOALANINE
Ligand Molecules
NVP
Primary Citation
Crystal structures of Zidovudine- or Lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215.
Chamberlain, P.P, Ren, J, Nichols, C.E, Douglas, L, Lennerstrand, J, Larder, B.A, Stuart, D.I, Stammers, D.K, Ren, J, Nichols, C.E, Bird, L.E, Chamberlain, P, Weaver, K.L, Short, S.A, Stuart, D.I, Stammers, D.K, Chan, J.H, Hong, J.S, Hunter III, R.N, Orr, G.F, Cowan, J.R, Sherman, D.B, Sparks, S.M, Reitter, B.E, Andrews III, C.W, Hazen, R.J, St Clair, M, Boone, L.R, Ferris, R.G, Creech, K.L, Roberts, G.B, Short, S.A, Weaver, K.L, Ott, R.J, Ren, J, Hopkins, A.L, Stuart, D.I, Stammers, D.K, Ren, J, Milton, J, Weaver, K.L, Short, S.A, Stuart, D.I, Stammers, D.K, Ren, J, Nichols, C.E, Bird, L.E, Fujiwara, T, Sugimoto, H, Stuart, D.I, Stammers, D.K, Ren, J, Diprose, J, Warren, J, Esnouf, R.M, Bird, L.E, Ikemizu, S, Slater, M, Milton, J, Balzarini, J, Stuart, D.I, Stammers, D.K, Ren, J, Esnouf, R.M, Hopkins, A.L, Stuart, D.I, Stammers, D.K, Hopkins, A.L, Ren, J, Tanaka, H, Baba, M, Okamato, M, Stuart, D.I, Stammers, D.K, Ren, J, Esnouf, R.M, Hopkins, A.L, Warren, J, Balzarini, J, Stuart, D.I, Stammers, D.K, Ren, J, Esnouf, R.M, Hopkins, A.L, Jones, E.Y, Kirby, I, Keeling, J, Ross, C.K, Larder, B.A, Stuart, D.I, Stammers, D.K, Esnouf, R.M, Ren, J, Garman, E.F, Somers, D.O, Ross, C.K, Jones, E.Y, Stammers, D.K, Stuart, D.I, Esnouf, R.M, Ren, J, Hopkins, A.L, Ross, C.K, Jones, E.Y, Stammers, D.K, Stuart, D.I, Hopkins, A.L, Ren, J, Esnouf, R.M, Willcox, B.E, Jones, E.Y, Ross, C.K, Miyasaka, T, Walker, R.T, Tanaka, H, Stammers, D.K, Stuart, D.I, Ren, J, Esnouf, R.M, Hopkins, A.L, Ross, C.K, Jones, E.Y, Stammers, D.K, Stuart, D.I, Ren, J, Esnouf, R.M, Garman, E, Somers, D.O, Ross, C.K, Kirby, I, Keeling, J, Darby, G, Jones, E.Y, Stuart, D.I, Stammers, D.K, Esnouf, R.M, Ren, J, Ross, C.K, Jones, E.Y, Stammers, D.K, Stuart, D.I, Stammers, D.K, Somers, D.O, Ross, C.K, Kirby, I, Ray, P.H, Wilson, J.E, Norman, M, Ren, J, Esnouf, R.M, Garman, E, Jones, E.Y, Stuart, D.I.Show
J.Virol. 76 10015 10019 (2002)
PMID: 12208978 DOI: 10.1128/JVI.76.19.10015-10019.2002

Abstact

Six structures of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) containing combinations of resistance mutations for zidovudine (AZT) (M41L and T215Y) or lamivudine (M184V) have been determined as inhibitor complexes. Minimal conformational changes in the polymerase or nonnucleoside RT inhibitor sites compared to the mutant RTMC (D67N, K70R, T215F, and K219N) are observed, indicating that such changes may occur only with certain combinations of mutations. Model building M41L and T215Y into HIV-1 RT-DNA and docking in ATP that is utilized in the pyrophosphorolysis reaction for AZT resistance indicates that some conformational rearrangement appears necessary in RT for ATP to interact simultaneously with the M41L and T215Y mutations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
1VRT
1RTH
1VRU
1RTI
1RTJ
1REV
1RT1
1RT2
1KLM
1RT3
1RT4
1RT5
1RT6
1RT7
1C0T
1C0U
1C1B
1C1C
1DTQ
1DTT
1EP4
1FK9
1FKO
1FKP
1JLA
1JLB
1JLC
1JLE
1JLF
1JLG
1JKH
1JLQ
1LW0
1LW2
1LWC
1LWE